Bioceres Crop Solutions Reports Q3 2025 Results

Ticker: BIOX · Form: 6-K · Filed: May 21, 2025 · CIK: 1769484

Sentiment: neutral

Topics: earnings-report, financial-results, foreign-private-issuer

TL;DR

Bioceres Crop Solutions dropped its Q3 2025 earnings report today.

AI Summary

Bioceres Crop Solutions Corp. reported its fiscal third quarter 2025 financial and operational results on May 21, 2025. The company is a foreign private issuer filing a Form 6-K, which typically includes press releases or other material information for international companies.

Why It Matters

This filing provides investors with an update on Bioceres Crop Solutions' financial performance and operational activities for the third quarter of fiscal year 2025.

Risk Assessment

Risk Level: low — This is a routine financial results filing (6-K) and does not appear to contain any immediately alarming or significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer providing information for the month of May 2025, specifically including a press release on fiscal third quarter 2025 financial and operational results.

What is Bioceres Crop Solutions Corp.'s fiscal year end?

Bioceres Crop Solutions Corp.'s fiscal year ends on June 30.

What is the Commission File Number for Bioceres Crop Solutions Corp.?

The Commission File Number for Bioceres Crop Solutions Corp. is 001-38836.

Where is Bioceres Crop Solutions Corp. located?

The company's principal executive offices are located at Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina.

What exhibit is included with this 6-K filing?

Exhibit 99.1 is included, which is a press release detailing Bioceres Crop Solutions Corp.'s fiscal third quarter 2025 financial and operational results.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding Bioceres Crop Solutions Corp. (BIOX).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing